Integrated genomics and phenotype microarray analysis of Saccharomyces cerevisiae industrial strains for rice wine fermentation and recombinant protein production.
Ye Ji SonMin-Seung JeonHye Yun MoonJiwon KangDa Min JeongDong Wook LeeJae Ho KimJae Yun LimJeong-Ah SeoJae-Hyung JinYong-Sun BahnSeong-Il EyunHyun Ah KangPublished in: Microbial biotechnology (2023)
The industrial potential of Saccharomyces cerevisiae has extended beyond its traditional use in fermentation to various applications, including recombinant protein production. Herein, comparative genomics was performed with three industrial S. cerevisiae strains and revealed a heterozygous diploid genome for the 98-5 and KSD-YC strains (exploited for rice wine fermentation) and a haploid genome for strain Y2805 (used for recombinant protein production). Phylogenomic analysis indicated that Y2805 was closely associated with the reference strain S288C, whereas KSD-YC and 98-5 were grouped with Asian and European wine strains, respectively. Particularly, a single nucleotide polymorphism (SNP) in FDC1, involved in the biosynthesis of 4-vinylguaiacol (4-VG, a phenolic compound with a clove-like aroma), was found in KSD-YC, consistent with its lack of 4-VG production. Phenotype microarray (PM) analysis showed that KSD-YC and 98-5 displayed broader substrate utilization than S288C and Y2805. The SNPs detected by genome comparison were mapped to the genes responsible for the observed phenotypic differences. In addition, detailed information on the structural organization of Y2805 selection markers was validated by Sanger sequencing. Integrated genomics and PM analysis elucidated the evolutionary history and genetic diversity of industrial S. cerevisiae strains, providing a platform to improve fermentation processes and genetic manipulation.
Keyphrases
- saccharomyces cerevisiae
- genome wide
- heavy metals
- escherichia coli
- single cell
- wastewater treatment
- genetic diversity
- air pollution
- particulate matter
- dna methylation
- protein protein
- amino acid
- healthcare
- lactic acid
- risk assessment
- binding protein
- cell free
- small molecule
- transcription factor
- copy number
- polycyclic aromatic hydrocarbons
- clinical evaluation